Tiffany Burnett

Senior Director, Biopharma Programs, Cystic Fibrosis Foundation

Tiffany has over two decades of broad drug development and leadership experience within the biotechnology and pharmaceutical industries. As part of her role at the Foundation, she co-leads the Infection Research Initiative, oversees the therapeutic development portfolio for infection, and helps with DEI community efforts. She is passionate about marrying science and advocacy in a meaningful and impactful way that benefits all. She enjoys spending time with her husband and two sons. She also enjoys gardening, cooking, sports, and music.